Genomic screening for hereditary conditions is cost-effective in young adults

1. In this decision analysis model, population screening for three common hereditary conditions was cost-effective in adults younger than 40. 2. Population genomic screening was particularly cost-effective if probands had access to preventative care. Evidence Rating Level: 1 (Excellent) Study Rundown: Population genomic screening for Lynch Syndrome (LS), hereditary breast and ovarian cancer syndrome (HBOC),

Related Keywords

Nevada ,United States , ,Centers For Disease ,Minute Medicine Inc ,Rating Level ,Lynch Syndrome ,Population Genomic Screening ,Three Common Hereditary ,Healthy Nevada Project ,Disease Control ,Prevention Tier ,Chronic Disease ,Familial Hypercholesterolemia Fh ,Genetic Screening ,Genetics ,Genomics ,Hereditary Breast And Ovarian Cancer Syndrome Hboc ,Lynch Syndrome Ls ,Public Health ,